Evidence map›Paper›PMID 40353411›Full record

ArticleProtein and peptide letters2025

Virtual Screening of Phytoconstituents in Indian Spices based on their Inhibitory Potential against SARS-CoV-2.

Vaishali Singh, Aliza Rabbani, Veda P Pandey

Abstract read
PubMed Publisher
In one paragraph

Article in Protein and peptide letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vaishali SinghDepartment of Biochemistry, University of Lucknow, Lucknow-226007, India.
Aliza RabbaniDepartment of Biochemistry, University of Lucknow, Lucknow-226007, India.
Veda P PandeyInstitute of Food Processing and Technology, ONGC Centre of Advanced Studies, University of Lucknow, Lucknow-226007, U.P., India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly pathogenic human coronavirus (CoV). For the treatment of COVID-19, various drugs, ayurvedic formulations, used for other diseases, were repurposed. Ayurveda and yoga exhibited a pivotal role in the treatment of COVID-19. Various medicinal plants, including garlic, tulsi, clove, cinnamon, ginger, black pepper, and turmeric, are recommended for the prevention of COVID-19 as immunity boosters along with their antiviral property.

objectiveIn view of the drug repurposing approach, the present work has been initiated with the broader objectives of screening and identification of phytoconstituents of Indian spices against targets, namely furin, 3C-like protease (3CL-PRO), NSP-9 RNA binding protein, papain-like protease, RNA dependent RNA polymerase (RDRP), spike protein concerned with life cycle of SARS-CoV-2 using in-silico tools.

methodsThe phytoconstituents of Indian spices were screened for interaction with several targets using a molecular docking approach with the help of Discovery Studio 4.5 software. Furthermore, the pharmacokinetic analyses of selected ligands using ADMET and Lipinski's rule of five were also performed.

resultsIn the present study, a total of 37 active phytoconstituents of Indian spices were screened for interaction with several identified targets of COVID-19 using a molecular docking approach. The ligands, namely morin, gingerol, myristic acid, quercetin, gallic acid and alliin were found to be the top interacting ligands with the targets analyzed.

conclusionBased on the present

Indexed as

Antiviral AgentsPhytochemicalsSpicesCatecholsCoronavirus 3C ProteasesCoronavirus Papain-Like ProteasesCOVID-19COVID-19 Drug TreatmentDrug RepositioningFatty AlcoholsFurinHumansIndiaMolecular Docking SimulationPandemicsSARS-CoV-23C-like proteinase, SARS-CoV-2Antiviral AgentsCatecholsCoronavirus 3C ProteasesCoronavirus Papain-Like ProteasesFatty AlcoholsFuringingerolPhytochemicalsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19ethnomedical literaturemolecular dockingpandemic.pharmacokinetics analysisphytoconstituents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.